Mazdutide is a dual GLP-1/glucagon agonist developed by Innovent Biologics, primarily studied in Chinese populations, showing weight loss of 14-18% in clinical trials
One group ate soy that didnt contain isoflavones, which are natural plant estrogens
"I do think we're all going to have to be a little bit patient, because there is probably going to be a bit of a strain on clinics and pharmacies for the next couple of months as people very excitedly start these medications," Francavilla said
Patients should expect continued follow-up, medication monitoring, and conversations about nutrition, activity, side effects, and progress
Route: The injection is typically given intramuscularly (IM) into a large muscle, such as the thigh or buttock, or subcutaneously (SC) into the subcutaneous tissue